ID
45491
Descripción
Principal Investigator: Matthew Meyerson, MD, PhD, Dana Farber Cancer Institute, Boston MA MeSH: Solitary Fibrous Tumors https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000568 Solitary fibrous tumors (SFTs) are rare mesenchymal tumors that can be benign or malignant. In this study, we sequenced and analyzed the exomes of 17 SFT matched tumor and normal pairs. This study appertains to a large endeavor to characterize cancers as part of the Slim Initiative for Genomic Medicine in the Americas (SIGMA) project.
Link
Palabras clave
Versiones (2)
- 31/10/22 31/10/22 - Simon Heim
- 13/12/22 13/12/22 - Kristina Keller
Titular de derechos de autor
Matthew Meyerson, MD, PhD, Dana Farber Cancer Institute, Boston MA
Subido en
13 de diciembre de 2022
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY 4.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
dbGaP phs000568 Genomic Sequencing of Solitary Fibrous Tumors
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID, subject source, subject source ID, consent group, and affection status of participants with solitary fibrous tumors and involved in the "Genomic Sequencing of Solitary Fibrous Tumors" project.
- Subject ID, sample ID, sample source, sample source ID, and sample use variable obtained from participants with solitary fibrous tumors and involved in the "Genomic Sequencing of Solitary Fibrous Tumors" project.
- Subject ID, age, sex, race, primary disease, and treatment received before surgery of participants with solitary fibrous tumors and involved in the "Genomic Sequencing of Solitary Fibrous Tumors" project.
- Sample ID, body site where sample was collected, analyte type of samples, tumor status, primary tumor, metastasis, or transformed cell line, and samples obtained from tumor after some treatment and associated with participants with solitary fibrous tumors and involved in the "Genomic Sequencing of Solitary Fibrous Tumors" project.
Similar models
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID, subject source, subject source ID, consent group, and affection status of participants with solitary fibrous tumors and involved in the "Genomic Sequencing of Solitary Fibrous Tumors" project.
- Subject ID, sample ID, sample source, sample source ID, and sample use variable obtained from participants with solitary fibrous tumors and involved in the "Genomic Sequencing of Solitary Fibrous Tumors" project.
- Subject ID, age, sex, race, primary disease, and treatment received before surgery of participants with solitary fibrous tumors and involved in the "Genomic Sequencing of Solitary Fibrous Tumors" project.
- Sample ID, body site where sample was collected, analyte type of samples, tumor status, primary tumor, metastasis, or transformed cell line, and samples obtained from tumor after some treatment and associated with participants with solitary fibrous tumors and involved in the "Genomic Sequencing of Solitary Fibrous Tumors" project.
C1266119 (UMLS CUI [1,2])
C5395609 (UMLS CUI [1,3])